SMTL ID : 6q4h.1

CDK2 in complex with FragLite36

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.00 Å

Oligo State

monomer

Ligands

1 x HGH: 2-[3-[(2-azanyl-9~{H}-purin-6-yl)oxy]phenyl]ethanoic acid(Non-covalent)

HGH.1: 15 residues within 4Å: Chain A: I.18, G.21, T.22, V.26, A.39, K.41, V.72, F.88, E.89, F.90, L.91, K.137, Q.139, L.142, A.152 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.18, A:V.26, A:V.26, A:Q.139 Hydrogen bonds: A:T.22, A:T.22, A:K.41, A:E.89, A:L.91, A:L.91, A:D.153 Water bridges: A:K.137, A:N.140 Salt bridges: A:K.137

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 6 residues within 4Å: Chain A: L.227, G.228, T.229, D.231, R.253, Y.277 2 PLIP interactions: 2 interactions with chain A Water bridges: A:R.253 Salt bridges: A:D.231

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wood, D.J. et al., FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation. J.Med.Chem. (2019)

Release Date

2019-03-20

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence